Virotherapy - Cancer targeted pharmacology

Virotherapy - Cancer targeted pharmacology

Toon andere (1) versies

Building on their success in vaccination, many groups are now exploring the use of viruses as anticancer agents. In general, viral therapeutics provide the possibility to express anticancer proteins directly at the tumour site, decreasing exposure to normal tissue during delivery and maximising ther...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Tedcastle, A, Cawood, R, Di, Y, Fisher, K, Seymour, L
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2012

Gelijkaardige items

Virotherapy--cancer targeted pharmacology.
door: Tedcastle, A, et al.
Gepubliceerd in: (2012)

Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.
door: Green, N, et al.
Gepubliceerd in: (2012)

Effects of Producer Cell Type on the Properties of Oncolytic Sindbis Virus
door: Kueberuwa, G, et al.
Gepubliceerd in: (2011)

Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.
door: Bazan-Peregrino, M, et al.
Gepubliceerd in: (2008)

Combining virotherapy and angiotherapy for the treatment of breast cancer.
door: Bazan-Peregrino, M, et al.
Gepubliceerd in: (2013)

Combining virotherapy and angiotherapy for the treatment of breast cancer
door: Bazan-Peregrino, M, et al.
Gepubliceerd in: (2013)

Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor.
door: Morrison, J, et al.
Gepubliceerd in: (2008)

716 Cell-based virotherapy for targeting cancers
door: Boris Minev, et al.
Gepubliceerd in: (2020-11-01)

Oncolytic virotherapy: combining first-rate science with an unmet clinical need.
door: Seymour, L
Gepubliceerd in: (2011)

Factors responsible for inhibition of adenovirus infection by cellular debris and tumour lysate
door: Tedcastle, A, et al.
Gepubliceerd in: (2011)

Virotherapy in Head and Neck Cancer
door: Zhan Wang
Gepubliceerd in: (2024-03-01)

Cavitation-enhanced tumour-targeting virotherapy by ultrasound
door: Mo, S
Gepubliceerd in: (2013)

Oncolytic virotherapy targeting the IL15 pathway
door: So Young Yoo, et al.
Gepubliceerd in: (2023-12-01)

Oncolytic Virotherapy of Canine and Feline Cancer
door: Ivaylo Gentschev, et al.
Gepubliceerd in: (2014-05-01)

Oncolytic virotherapy
door: Daniel Cervantes-García;, et al.
Gepubliceerd in: (2008-01-01)

Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer
door: Khandoker Usran Ferdous, et al.
Gepubliceerd in: (2024-07-01)

Oncolytic Virotherapy for Cancer: Clinical Experience
door: Shyambabu Chaurasiya, et al.
Gepubliceerd in: (2021-04-01)

Multidisciplinary oncolytic virotherapy for gastrointestinal cancer
door: Toshiyoshi Fujiwara
Gepubliceerd in: (2019-07-01)

Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth
door: Tedcastle, A, et al.
Gepubliceerd in: (2016)

Modeling dynamics of cancer virotherapy with immune response
door: Salma M. Al-Tuwairqi, et al.
Gepubliceerd in: (2020-08-01)

Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination
door: D. G. Roy, et al.
Gepubliceerd in: (2021-05-01)

Editorial: Oncolytic virotherapy
door: Ahmed Majeed Al-Shammari, et al.
Gepubliceerd in: (2023-11-01)

Advances in oncolytic virotherapy
door: Stephen J. Russell, et al.
Gepubliceerd in: (2022-04-01)

Improving intraperitoneal adenovirus virotherapy for ovarian cancer
door: Thoma, CMM
Gepubliceerd in: (2011)

Lung cancer and oncolytic virotherapy——enemy's enemy
door: Zhang Li, et al.
Gepubliceerd in: (2023-01-01)

DNA-damaging cancer cells to improve virotherapy
door: Marc Garcia-Moure, et al.
Gepubliceerd in: (2022-12-01)

Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound.
door: Carlisle, R, et al.
Gepubliceerd in: (2013)

Oncolytic virotherapy – A novel strategy for cancer therapy
door: Mohanan Geetha Gopisankar, et al.
Gepubliceerd in: (2018-07-01)

Oncolytic Virotherapy for Hematological Malignancies
door: Swarna Bais, et al.
Gepubliceerd in: (2012-01-01)

Mathematical modelling of oncolytic virotherapy
door: Shabala, A
Gepubliceerd in: (2013)

Cellular carriers or free viruses?
door: Seymour, L, et al.
Gepubliceerd in: (2008)

Recombinant viral vaccines for cancer
door: Cawood, R, et al.
Gepubliceerd in: (2012)

Recombinant viral vaccines for cancer.
door: Cawood, R, et al.
Gepubliceerd in: (2012)

Oncolytic virotherapy in head and neck cancer: A hope?
door: Vishnu Priya Veeraraghavan, et al.
Gepubliceerd in: (2024-03-01)

Oncolytic virotherapy in cancer treatment: challenges and optimization prospects
door: Lingjuan Chen, et al.
Gepubliceerd in: (2023-12-01)

Oncolytic virotherapy in gastric cancer: Towards precision therapeutics
door: Muhammad Ikrama, et al.
Gepubliceerd in: (2024-04-01)

Current perspectives of virotherapy as a cancer treatment strategy
door: Lyubov D. Vlasova
Gepubliceerd in: (2024-12-01)

An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy
door: Muhammad Naveed, et al.
Gepubliceerd in: (2024-11-01)

The combination therapy of oncolytic virotherapy
door: Yue Wang, et al.
Gepubliceerd in: (2024-04-01)

Syncytia Formation in Oncolytic Virotherapy
door: Chase Burton, et al.
Gepubliceerd in: (2019-12-01)